Planet 13 Holdings (PLNH) Change in Receivables (2022 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Change in Receivables of -$2.5 million for Q1 2026, down 1666.45% year-over-year from $160964.0 in Q1 2025, and down 2162.68% quarter-over-quarter from $122240.0 in Q3 2025.
Planet 13 Holdings (PLNH) Change in Receivables (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Change in Receivables for 5 consecutive years, with -$2.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables fell 1666.45% year-over-year to -$2.5 million; the TTM figure through Mar 2026 stood at -$2.3 million (down 480.32% YoY), while the FY2024 annual figure was $277229.0, up 311.84% from the prior year.
- Change in Receivables retreated to -$2.5 million in Q1 2026 per PLNH's latest filing, from $122240.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $217536.0 in Q3 2024 and bottomed at -$2.5 million in Q1 2026.
- Historically, Change in Receivables has averaged -$177838.2 across 5 years, with a median of -$1547.0 in 2022.
- Annual changes were most pronounced in 2024 — Change in Receivables soared 835.42% — and 2026, when it tumbled 1666.45%.
- Planet 13 Holdings' Change in Receivables stood at $21188.0 in 2022, then slumped by 214.6% to -$24282.0 in 2023, then jumped by 835.42% to $178575.0 in 2024, then sank by 31.55% to $122240.0 in 2025, then slumped by 2162.68% to -$2.5 million in 2026.
- Business Quant data shows PLNH's Change in Receivables at -$2.5 million in Q1 2026, $122240.0 in Q3 2025, and -$38619.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Planet 13 Holdings | 47.95 Mn | 31.46 Mn | 12.32 Mn | -244,608.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -244,608.00 |
| Jun 30, 2026 | -244,608.00 |
| Mar 31, 2026 | -2.52 Mn |
| Mar 31, 2026 | -2.52 Mn |
| Sep 30, 2025 | 122,240.00 |
| Sep 30, 2025 | 122,240.00 |
| Jun 30, 2025 | -38,619.00 |
| Jun 30, 2025 | -38,619.00 |
| Mar 31, 2025 | 160,964.00 |
| Mar 31, 2025 | 160,964.00 |
| Dec 31, 2024 | 178,575.00 |
| Dec 31, 2024 | 178,575.00 |
| Sep 30, 2024 | 217,536.00 |
| Sep 30, 2024 | 217,536.00 |
| Jun 30, 2024 | 41,580.00 |
| Jun 30, 2024 | 41,580.00 |
| Mar 31, 2024 | -160,462.00 |
| Mar 31, 2024 | -160,462.00 |
| Dec 31, 2023 | -24,282.00 |
| Dec 31, 2023 | -24,282.00 |